Based on innovative scientific achievements, PimedBio's first-in-class drugs

PimedBio is moving forward step by step to realize the dream of better human health.

Platform

Platform

Pluripotential Target Discovery

We identify pluripotential targets—proteins that participate multiple core pathways related to initiation and progression of a disease—through the analysis of big data for drug discovery and development

Innovative Drug Desig

Against the identified target, we design, ensuring safety and efficacy, small molecules leads and candidates based on various modalities such as protein targeted degraders(PTD), bispecific small-molecules(BSM) and inhibitor-drug conjugates(IDC).